<?xml version="1.0" encoding="UTF-8"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"><url><loc>https://supplementbrief.com/akkermansia-glp1-probiotic/</loc><image:image><image:loc>https://supplementbrief.com/_astro/akkermansia-glp1-probiotic.Vji7UI00_ZIiGdw.jpg</image:loc><image:title>Akkermansia and GLP-1 Probiotics: Evidence Check</image:title></image:image><image:image><image:loc>https://supplementbrief.com/images/charts/akk-shelf-doses.webp</image:loc><image:title>Akkermansia and GLP-1 Probiotics: Evidence Check</image:title><image:caption>Figure 1. Three products, three incomparable unit systems. Nothing on the shelf tells you what dose the trials used.</image:caption></image:image><image:image><image:loc>https://supplementbrief.com/images/charts/akk-trials-ladder.webp</image:loc><image:title>Akkermansia and GLP-1 Probiotics: Evidence Check</image:title><image:caption>Figure 2. The whole human record at a glance: one clear win in weight maintenance, two null primaries, and a pilot whose famous numbers were secondary endpoints.</image:caption></image:image><image:image><image:loc>https://supplementbrief.com/images/charts/akk-glp1-ladder.webp</image:loc><image:title>Akkermansia and GLP-1 Probiotics: Evidence Check</image:title><image:caption>Figure 3. The GLP-1 ladder. The top rung, Akkermansia tested alongside actual GLP-1 drugs, is empty: no such trial is registered anywhere.</image:caption></image:image></url><url><loc>https://supplementbrief.com/berberine-vs-ozempic/</loc><image:image><image:loc>https://supplementbrief.com/_astro/berberine-vs-ozempic.k2QmDHb-_ACgyp.jpg</image:loc><image:title>Berberine vs Ozempic: What It Can and Cannot Do</image:title></image:image></url><url><loc>https://supplementbrief.com/berberine-with-semaglutide/</loc><image:image><image:loc>https://supplementbrief.com/_astro/berberine-with-semaglutide.CKH_YENM_1yOR2v.jpg</image:loc><image:title>Can You Take Berberine With Semaglutide (Ozempic)?</image:title></image:image><image:image><image:loc>https://supplementbrief.com/images/charts/berberine-semaglutide-scale-gap.webp</image:loc><image:title>Can You Take Berberine With Semaglutide (Ozempic)?</image:title><image:caption>Figure 1. The medication moves double-digit percentages; the supplement&apos;s pooled estimates move fractions of a kilogram.</image:caption></image:image><image:image><image:loc>https://supplementbrief.com/images/charts/berberine-lei-endpoint-scorecard.webp</image:loc><image:title>Can You Take Berberine With Semaglutide (Ozempic)?</image:title><image:caption>Figure 2. The strongest berberine trial missed both fat primaries; the wins were lipids and safety, not weight.</image:caption></image:image><image:image><image:loc>https://supplementbrief.com/images/charts/berberine-glp1-risk-ladder.webp</image:loc><image:title>Can You Take Berberine With Semaglutide (Ozempic)?</image:title><image:caption>Figure 3. The grade climbs with what else is lowering glucose: low on a GLP-1 alone, moderate with berberine, major with insulin or a sulfonylurea.</image:caption></image:image></url><url><loc>https://supplementbrief.com/biotin-for-hair-loss/</loc><image:image><image:loc>https://supplementbrief.com/_astro/biotin-for-hair-loss.BN-aUWjf_Z1pPOe0.jpg</image:loc><image:title>Biotin for Hair Loss: The Marketing Myth vs The Evidence</image:title></image:image></url><url><loc>https://supplementbrief.com/collagen-loose-skin-after-ozempic/</loc><image:image><image:loc>https://supplementbrief.com/_astro/collagen-loose-skin-after-ozempic.EUEzJp3u_1OHgS9.jpg</image:loc><image:title>Collagen Won&apos;t Fix Loose Skin After Ozempic</image:title></image:image><image:image><image:loc>https://supplementbrief.com/images/charts/collagen-ozempic-three-problems.webp</image:loc><image:title>Collagen Won&apos;t Fix Loose Skin After Ozempic</image:title><image:caption>Figure 1. Marketing collapses three problems into one powder, while the trials only speak to the third column.</image:caption></image:image><image:image><image:loc>https://supplementbrief.com/images/charts/collagen-ozempic-trial-mismatch.webp</image:loc><image:title>Collagen Won&apos;t Fix Loose Skin After Ozempic</image:title><image:caption>Figure 2. Same word on the tub, but a different population, a different endpoint, and a different clinical problem.</image:caption></image:image><image:image><image:loc>https://supplementbrief.com/images/charts/collagen-ozempic-evidence-funnel.webp</image:loc><image:title>Collagen Won&apos;t Fix Loose Skin After Ozempic</image:title><image:caption>Figure 3. The evidence funnel ends empty where the reader problem actually lives.</image:caption></image:image></url><url><loc>https://supplementbrief.com/collagen-peptides-for-skin/</loc><image:image><image:loc>https://supplementbrief.com/_astro/collagen-peptides-for-skin.Cc8yUbv5_d1ieS.jpg</image:loc><image:title>Collagen Peptides for Skin: What Actually Has Evidence?</image:title></image:image></url><url><loc>https://supplementbrief.com/constipation-on-glp1/</loc><image:image><image:loc>https://supplementbrief.com/_astro/constipation-on-glp1.I2ujyCqy_1S1Ko7.jpg</image:loc><image:title>Ozempic Constipation: Fiber, Magnesium and Probiotics</image:title></image:image><image:image><image:loc>https://supplementbrief.com/images/charts/cgs-trial-rates.webp</image:loc><image:title>Ozempic Constipation: Fiber, Magnesium and Probiotics</image:title><image:caption>Figure 1. Constipation in the pivotal programs, drug arm versus placebo. The tirzepatide bar spans the label range across 5 to 15 mg.</image:caption></image:image><image:image><image:loc>https://supplementbrief.com/images/charts/cgs-fiber-forms.webp</image:loc><image:title>Ozempic Constipation: Fiber, Magnesium and Probiotics</image:title><image:caption>Figure 2. Form physics, ranked for a slowed-transit gut: gel-forming and fermentation-resistant beats fermentable.</image:caption></image:image><image:image><image:loc>https://supplementbrief.com/images/charts/cgs-magnesium-forms.webp</image:loc><image:title>Ozempic Constipation: Fiber, Magnesium and Probiotics</image:title><image:caption>Figure 3. Forms against evidence. The constipation trials belong to oxide; the marketing belongs to the forms without trials.</image:caption></image:image><image:image><image:loc>https://supplementbrief.com/images/charts/cgs-probiotics-strains.webp</image:loc><image:title>Ozempic Constipation: Fiber, Magnesium and Probiotics</image:title><image:caption>Figure 4. Where the strain evidence actually stands. The shelf sells the format the meta-analysis could not validate.</image:caption></image:image></url><url><loc>https://supplementbrief.com/creatine-for-women-over-40/</loc><image:image><image:loc>https://supplementbrief.com/_astro/creatine-for-women-over-40.dzWvdmz5_9cI9g.jpg</image:loc><image:title>Creatine for Women Over 40: Trials vs. the Marketing</image:title></image:image><image:image><image:loc>https://supplementbrief.com/images/charts/creatine-women40-evidence-map.webp</image:loc><image:title>Creatine for Women Over 40: Trials vs. the Marketing</image:title><image:caption>Figure 1. Muscle and safety have the clearest human data; brain and mood claims need tighter caveats.</image:caption></image:image><image:image><image:loc>https://supplementbrief.com/images/charts/creatine-women40-srma-outcomes.webp</image:loc><image:title>Creatine for Women Over 40: Trials vs. the Marketing</image:title><image:caption>Figure 2. The headline numbers assume resistance training and roughly 5 g/day monohydrate.</image:caption></image:image><image:image><image:loc>https://supplementbrief.com/images/charts/creatine-women40-dose-safety.webp</image:loc><image:title>Creatine for Women Over 40: Trials vs. the Marketing</image:title><image:caption>Figure 3. Monohydrate dose is simple; tell your clinician before labs if you supplement.</image:caption></image:image></url><url><loc>https://supplementbrief.com/electrolytes-on-ozempic/</loc><image:image><image:loc>https://supplementbrief.com/_astro/electrolytes-on-ozempic.uQcfB71J_1lc5wE.jpg</image:loc><image:title>Ozempic Electrolytes: Dehydration, Fatigue &amp; What Helps</image:title></image:image></url><url><loc>https://supplementbrief.com/finasteride-and-supplements/</loc><image:image><image:loc>https://supplementbrief.com/_astro/finasteride-and-supplements.BUUkO0xp_1D19nF.jpg</image:loc><image:title>Finasteride and Supplements: What the Trials Say</image:title></image:image><image:image><image:loc>https://supplementbrief.com/images/charts/fin-kaufman-hair-counts.webp</image:loc><image:title>Finasteride and Supplements: What the Trials Say</image:title><image:caption>Figure 1. The yardstick: two-year hair counts from the pivotal trials in 1,553 men.</image:caption></image:image><image:image><image:loc>https://supplementbrief.com/images/charts/fin-creatine-myth-ladder.webp</image:loc><image:title>Finasteride and Supplements: What the Trials Say</image:title><image:caption>Figure 2. Sixteen years apart: a hormone shift without hair data, then hair data without a hormone shift.</image:caption></image:image><image:image><image:loc>https://supplementbrief.com/images/charts/fin-ashwagandha-testosterone.webp</image:loc><image:title>Finasteride and Supplements: What the Trials Say</image:title><image:caption>Figure 3. The testosterone effect is real in trials; its hair consequence on finasteride is unmeasured.</image:caption></image:image><image:image><image:loc>https://supplementbrief.com/images/charts/fin-saw-palmetto-headtohead.webp</image:loc><image:title>Finasteride and Supplements: What the Trials Say</image:title><image:caption>Figure 4. Same target, different potency: the two-year head-to-head in 100 men.</image:caption></image:image></url><url><loc>https://supplementbrief.com/glp-1-companion-supplements/</loc><image:image><image:loc>https://supplementbrief.com/_astro/glp-1-companion-supplements.7j9BwIYe_gpVSU.jpg</image:loc><image:title>Best GLP-1 Companion Supplements 2026: Practical Framework</image:title></image:image></url><url><loc>https://supplementbrief.com/hair-loss-after-weight-loss/</loc><image:image><image:loc>https://supplementbrief.com/_astro/hair-loss-weight-loss.BKZRZANU_Z1nobMQ.jpg</image:loc><image:title>Hair Loss After Weight Loss: What Actually Helps</image:title></image:image></url><url><loc>https://supplementbrief.com/how-to-read-supplement-label/</loc><image:image><image:loc>https://supplementbrief.com/_astro/how-to-read-supplement-label.Bti50msp_ZigMOT.jpg</image:loc><image:title>How to Read a Supplement Label: The 90-Second Checklist Before You Buy</image:title></image:image></url><url><loc>https://supplementbrief.com/l-citrulline-vs-l-arginine-for-ed/</loc><image:image><image:loc>https://supplementbrief.com/_astro/l-citrulline-vs-l-arginine-for-ed.CavFU7CS_1AeLPR.jpg</image:loc><image:title>L-Citrulline for ED: 2024 Systematic Review</image:title></image:image></url><url><loc>https://supplementbrief.com/magnesium-forms-compared/</loc><image:image><image:loc>https://supplementbrief.com/_astro/magnesium-forms-compared.1H2NCQE8_13d50P.jpg</image:loc><image:title>Magnesium Forms Compared: Which One Actually Works?</image:title></image:image></url><url><loc>https://supplementbrief.com/metformin-b12-deficiency-which-form/</loc><image:image><image:loc>https://supplementbrief.com/_astro/metformin-b12-deficiency-which-form.isEDHKZV_Z2wlRvs.jpg</image:loc><image:title>Metformin and B12 Deficiency: Which Form Helps</image:title></image:image><image:image><image:loc>https://supplementbrief.com/images/charts/metformin-b12-absorption-pathway.webp</image:loc><image:title>Metformin and B12 Deficiency: Which Form Helps</image:title><image:caption>Figure 1. Metformin blocks the normal IF-dependent route; high-dose oral repletion uses passive diffusion. Prior stomach or major GI surgery may make IM preferable—dose beats form.</image:caption></image:image><image:image><image:loc>https://supplementbrief.com/images/charts/metformin-b12-prevalence.webp</image:loc><image:title>Metformin and B12 Deficiency: Which Form Helps</image:title><image:caption>Figure 2. Pooled risk data from Yang and Kakarlapudi meta-analyses. Higher dose and longer duration increase signal; population neuropathy prevalence was not proven higher.</image:caption></image:image><image:image><image:loc>https://supplementbrief.com/images/charts/metformin-b12-lab-decision.webp</image:loc><image:title>Metformin and B12 Deficiency: Which Form Helps</image:title><image:caption>Figure 3. Screening triggers from ADA and MUI cohort data. Prior stomach or major GI surgery and dyspeptic symptoms can justify earlier testing; gray-zone B12 often needs MMA or HoloTC before form shopping.</image:caption></image:image></url><url><loc>https://supplementbrief.com/nitric-oxide-ed-supplements/</loc><image:image><image:loc>https://supplementbrief.com/_astro/nitric-oxide-ed-supplements.CIdY3B09_xp4oU.jpg</image:loc><image:title>Nitric Oxide &amp; ED: What Supplements Actually Do</image:title></image:image><image:image><image:loc>https://supplementbrief.com/images/charts/no-ed-stacking-risk.webp</image:loc><image:title>Nitric Oxide &amp; ED: What Supplements Actually Do</image:title><image:caption>Each path alone can lower blood pressure a little. Self-stacking from the supplement aisle adds the effects together. That is why combination data comes from supervised trials, not DIY stacking.</image:caption></image:image></url><url><loc>https://supplementbrief.com/nutrafol-vs-minoxidil/</loc><image:image><image:loc>https://supplementbrief.com/_astro/nutrafol-vs-minoxidil.cUxSu7hC_Z1o6tvd.jpg</image:loc><image:title>Nutrafol vs Minoxidil: Which Actually Regrows Hair?</image:title></image:image></url><url><loc>https://supplementbrief.com/omega-3-for-inflammation/</loc><image:image><image:loc>https://supplementbrief.com/_astro/omega-3-inflammation.4k1jzhz3_ZkIJdh.jpg</image:loc><image:title>Omega-3 for Inflammation: What the 2026 Evidence Says</image:title></image:image></url><url><loc>https://supplementbrief.com/orforglipron-vs-semaglutide/</loc><image:image><image:loc>https://supplementbrief.com/_astro/orforglipron-foundayo.JbZJOVnk_Z1uDtud.jpg</image:loc><image:title>Orforglipron vs Semaglutide (Ozempic): 2026 Comparison</image:title></image:image><image:image><image:loc>https://supplementbrief.com/images/charts/glp1-weight-loss.webp</image:loc><image:title>Orforglipron vs Semaglutide (Ozempic): 2026 Comparison</image:title><image:caption>Mean weight loss across GLP-1 options in obesity without diabetes from separate trials. Orforglipron (highlighted) sits below both Wegovy injection doses and near the Wegovy pill on raw means; a 2026 ITC after population adjustment favors oral semaglutide 25 mg by roughly three percentage points.</image:caption></image:image></url><url><loc>https://supplementbrief.com/panax-ginseng-for-ed/</loc><image:image><image:loc>https://supplementbrief.com/_astro/panax-ginseng-for-ed.BoocOfYm_ZMr5qx.jpg</image:loc><image:title>Does Korean Red Ginseng Work for ED? Dose, Timing, and How It Compares With Viagra</image:title></image:image><image:image><image:loc>https://supplementbrief.com/images/charts/ginseng-ed-iief.webp</image:loc><image:title>Does Korean Red Ginseng Work for ED? Dose, Timing, and How It Compares With Viagra</image:title><image:caption>de Andrade 2007 sits near the IIEF-5 clinical threshold. Cochrane&apos;s pooled estimates for both IIEF-15 and IIEF-5 sit below MCID: statistically detectable, clinically small on average.</image:caption></image:image></url><url><loc>https://supplementbrief.com/protein-for-glp1/</loc><image:image><image:loc>https://supplementbrief.com/_astro/protein-for-glp1.DaqU1Y2w_Za88Rs.jpg</image:loc><image:title>GLP-1 Protein Powders: What Won&apos;t Upset Your Stomach</image:title></image:image></url><url><loc>https://supplementbrief.com/retatrutide-companion-nutrition/</loc><image:image><image:loc>https://supplementbrief.com/_astro/retatrutide-companion-nutrition.I5EXAP7X_1II4OE.jpg</image:loc><image:title>Retatrutide: Nutrition at 30% Weight Loss</image:title></image:image><image:image><image:loc>https://supplementbrief.com/images/charts/rt-lean-mass-share.webp</image:loc><image:title>Retatrutide: Nutrition at 30% Weight Loss</image:title><image:caption>Figure 1. The lean-mass share across the incretin class. Retatrutide&apos;s bar is dashed because the Phase 2 DXA paper described the proportion as similar without publishing the number.</image:caption></image:image></url><url><loc>https://supplementbrief.com/rosemary-oil-vs-minoxidil/</loc><image:image><image:loc>https://supplementbrief.com/_astro/rosemary-oil-vs-minoxidil.BF6OaOJK_1ce5D7.jpg</image:loc><image:title>Rosemary Oil vs 2% Minoxidil: 2015 Trial Review</image:title></image:image></url><url><loc>https://supplementbrief.com/semaglutide-birth-control/</loc><image:image><image:loc>https://supplementbrief.com/_astro/semaglutide-birth-control.B7gV-0Qm_2g404g.jpg</image:loc><image:title>Semaglutide and Birth Control: Absorption, Labels, Gaps</image:title></image:image><image:image><image:loc>https://supplementbrief.com/images/charts/sbc-two-verdicts.webp</image:loc><image:title>Semaglutide and Birth Control: Absorption, Labels, Gaps</image:title><image:caption>Figure 1. Same question, two labels: semaglutide sat inside the equivalence band, and tirzepatide&apos;s peaks fell by half while total exposure fell by a fifth.</image:caption></image:image><image:image><image:loc>https://supplementbrief.com/images/charts/sbc-four-week-windows.webp</image:loc><image:title>Semaglutide and Birth Control: Absorption, Labels, Gaps</image:title><image:caption>Figure 2. The interaction has a clock: strongest at the start, fading as the gut adapts, reopening at every dose step.</image:caption></image:image><image:image><image:loc>https://supplementbrief.com/images/charts/sbc-pregnancy-signals.webp</image:loc><image:title>Semaglutide and Birth Control: Absorption, Labels, Gaps</image:title><image:caption>Figure 3. The pooled human estimates sit at or around the null line; the labels keep the planning rules because certainty is low.</image:caption></image:image></url><url><loc>https://supplementbrief.com/st-johns-wort-with-antidepressants/</loc><image:image><image:loc>https://supplementbrief.com/_astro/st-johns-wort-with-antidepressants.DNF-BUnM_2lXmlq.jpg</image:loc><image:title>St John&apos;s Wort With Antidepressants and Birth Control</image:title></image:image><image:image><image:loc>https://supplementbrief.com/images/charts/sjw-evidence-both-sides.webp</image:loc><image:title>St John&apos;s Wort With Antidepressants and Birth Control</image:title><image:caption>Figure 1. The herb clears the efficacy bar in trials and clears out a list of drug levels in clinics; both ledgers belong to the same chemistry.</image:caption></image:image><image:image><image:loc>https://supplementbrief.com/images/charts/sjw-pxr-enzyme-cascade.webp</image:loc><image:title>St John&apos;s Wort With Antidepressants and Birth Control</image:title><image:caption>Figure 2. The interaction is transcriptional, and that is why it builds over days and outlasts the last dose.</image:caption></image:image><image:image><image:loc>https://supplementbrief.com/images/charts/sjw-contraception-two-extracts.webp</image:loc><image:title>St John&apos;s Wort With Antidepressants and Birth Control</image:title><image:caption>Figure 3. Same question, opposite answers: the variable is hyperforin, and the label does not mention it.</image:caption></image:image><image:image><image:loc>https://supplementbrief.com/images/charts/sjw-induction-timeline.webp</image:loc><image:title>St John&apos;s Wort With Antidepressants and Birth Control</image:title><image:caption>Figure 4. The interaction has a clock: it builds, it holds, and it lingers after the bottle is empty.</image:caption></image:image></url><url><loc>https://supplementbrief.com/supplement-industry-mid-2026/</loc><image:image><image:loc>https://supplementbrief.com/_astro/supplement-industry-mid-2026.C7DqeiED_Z1VP9Nc.jpg</image:loc><image:title>Supplement Trends and Hype 2026: What Won&apos;t Survive 2027</image:title></image:image><image:image><image:loc>https://supplementbrief.com/images/charts/industry-four-shows-mid2026.webp</image:loc><image:title>Supplement Trends and Hype 2026: What Won&apos;t Survive 2027</image:title><image:caption>Figure 1. Four H1 2026 shows, four questions before a trend lands in your cart: problem, evidence tier, panel, daily use.</image:caption></image:image><image:image><image:loc>https://supplementbrief.com/images/charts/glp1-prescription-landscape-mid2026.webp</image:loc><image:title>Supplement Trends and Hype 2026: What Won&apos;t Survive 2027</image:title><image:caption>Figure 2. Prescription GLP-1 headlines that rewrote booth copy in spring 2026 — supplements are not in this drug class.</image:caption></image:image><image:image><image:loc>https://supplementbrief.com/images/charts/industry-narrative-shift-2025-2026.webp</image:loc><image:title>Supplement Trends and Hype 2026: What Won&apos;t Survive 2027</image:title><image:caption>Figure 3. How 2026 layered scenario SKUs and tighter claims onto 2025 social-ingredient hype, not a dollar forecast.</image:caption></image:image><image:image><image:loc>https://supplementbrief.com/images/charts/industry-chews-rtd-buy-skip-mid2026.webp</image:loc><image:title>Supplement Trends and Hype 2026: What Won&apos;t Survive 2027</image:title><image:caption>Figure 4. Chews and RTDs, dose, sugar, polyol, and stacking rules (Buy / Skip callouts below).</image:caption></image:image></url><url><loc>https://supplementbrief.com/supplement-label-vs-lab-dsid/</loc><image:image><image:loc>https://supplementbrief.com/_astro/supplement-label-vs-lab-dsid.Bqcf27Zn_Z1C94V2.jpg</image:loc><image:title>Supplement Labels vs Lab: What NIH DSID Actually Measured</image:title></image:image><image:image><image:loc>https://supplementbrief.com/images/charts/dsid-adult-mvm-estimates.webp</image:loc><image:title>Supplement Labels vs Lab: What NIH DSID Actually Measured</image:title><image:caption>Figure 1. DSID regression-derived estimates as percent of labeled at common adult MVM label levels (category 05, 2011–12 purchase cohort). Bars above 100% mean category estimates above stated label amounts at that label level.</image:caption></image:image><image:image><image:loc>https://supplementbrief.com/images/charts/dsid-adult-mvm-rounds-drift.webp</image:loc><image:title>Supplement Labels vs Lab: What NIH DSID Actually Measured</image:title><image:caption>Figure 2. Measured-to-label differences in two DSID adult MVM rounds at matched label levels. Descriptive comparison only; not a trend claim.</image:caption></image:image></url><url><loc>https://supplementbrief.com/supplements-for-mirtazapine-weight-gain/</loc><image:image><image:loc>https://supplementbrief.com/_astro/supplements-for-mirtazapine-weight-gain.CIseUFh4_1NLrs.jpg</image:loc><image:title>Supplements for mirtazapine weight gain: evidence review</image:title></image:image><image:image><image:loc>https://supplementbrief.com/images/charts/mirtazapine-comparison.webp</image:loc><image:title>Supplements for mirtazapine weight gain: evidence review</image:title><image:caption>Figure. Effect sizes are point estimates from the largest or most rigorous meta-analysis available; berberine&apos;s range reflects meta-analytic disagreement (−0.88 kg in the largest, up to −2.07 kg in another). All evidence is from general overweight/obese populations — no supplement has a trial in mirtazapine-treated patients.</image:caption></image:image></url><url><loc>https://supplementbrief.com/supplements-for-ssri-induced-ed/</loc><image:image><image:loc>https://supplementbrief.com/_astro/supplements-for-ssri-induced-ed.Baj9UCe0_2d6pna.jpg</image:loc><image:title>Supplements for SSRI-induced ED: what the evidence actually shows</image:title></image:image></url><url><loc>https://supplementbrief.com/third-party-certification-explained/</loc><image:image><image:loc>https://supplementbrief.com/_astro/third-party-certification-explained.BvyEAdgd_28RF7i.jpg</image:loc><image:title>What Does Third-Party Tested Mean? NSF, USP, ConsumerLab</image:title></image:image><image:image><image:loc>https://supplementbrief.com/images/charts/third-party-certifier-matrix.webp</image:loc><image:title>What Does Third-Party Tested Mean? NSF, USP, ConsumerLab</image:title><image:caption>Figure. Read each row as: &quot;what does this seal prove if I see it on a bottle?&quot; A product with USP Verified has passed identity, potency, purity, and dissolution testing. A product with Informed Choice has passed a banned-substance screen on a sample bought at retail. They answer different questions &amp;mdash; the matrix shows which.</image:caption></image:image><image:image><image:loc>https://supplementbrief.com/images/charts/third-party-certifier-decision.webp</image:loc><image:title>What Does Third-Party Tested Mean? NSF, USP, ConsumerLab</image:title><image:caption>Figure. The decision comes down to one question for most readers. The rest is matching the seal to what you actually need verified.</image:caption></image:image></url><url><loc>https://supplementbrief.com/urolithin-a-vs-nmn/</loc><image:image><image:loc>https://supplementbrief.com/_astro/urolithin-a-vs-nmn.WRfrQmZF_15tRX5.jpg</image:loc><image:title>Urolithin A vs NMN: What Human Trials Actually Show</image:title></image:image><image:image><image:loc>https://supplementbrief.com/images/charts/urolithin-nourish-plasma-pk.webp</image:loc><image:title>Urolithin A vs NMN: What Human Trials Actually Show</image:title><image:caption>Figure 1. Food is not a standardized intervention — direct Mitopure bypasses the microbiome lottery and delivers higher, faster plasma exposure.</image:caption></image:image><image:image><image:loc>https://supplementbrief.com/images/charts/urolithin-atlas-endpoints.webp</image:loc><image:title>Urolithin A vs NMN: What Human Trials Actually Show</image:title><image:caption>Figure 2. The ~12% hamstring stat from ads is real but secondary — the pre-specified primary endpoint (peak power output) did not win, and handgrip did not separate from placebo.</image:caption></image:image></url><url><loc>https://supplementbrief.com/winter-blues-supplements/</loc><image:image><image:loc>https://supplementbrief.com/_astro/winter-blues-supplements.Ccu68qBa_ZgTw54.jpg</image:loc><image:title>Winter Blues: 3 Supplements With Real Evidence</image:title></image:image><image:image><image:loc>https://supplementbrief.com/images/charts/saffron-depression-forest.webp</image:loc><image:title>Winter Blues: 3 Supplements With Real Evidence</image:title><image:caption>Saffron separates from placebo (moderate effect, though the CI touches zero). Against fluoxetine, the CI crosses zero: saffron is statistically indistinguishable from a low-dose SSRI in these trials. Source: Khaksarian et al., 2019 [14] (meta-analysis of 8 RCTs).</image:caption></image:image><image:image><image:loc>https://supplementbrief.com/images/charts/chronobiological-day.webp</image:loc><image:title>Winter Blues: 3 Supplements With Real Evidence</image:title><image:caption>Illustrative schedule; adjust to your wake time. The logic: morning light sets the phase, daytime supplements stack on a fed base, melatonin arrives early enough to advance the clock (not at bedtime to sedate), and darkness hygiene lets endogenous melatonin rise. Sources: AAFP 2020 [5] ; Mundey 2005 [1] ; Khaksarian 2019 [14] .</image:caption></image:image></url></urlset>